Claim 20% Off With Code ONLINE20 – Explore Market Reports Covering Trade Trends, Regulatory Changes, and Growth Insights
How Is the Multiomics Services Market Growth Forecast from 2025 to 2029?
The multiomics services market size has grown exponentially in recent years. It will grow from $1.18 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to rising availability of next-generation sequencing platforms, increasing use of bioinformatics tools in research, growing demand for biomarker discovery, rising academic collaborations in systems biology, and growing utility of multiomics in plant science.
The multiomics services market size is expected to see exponential growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to the rise of sustainable agriculture practices, increasing focus on single-cell multiomics, growing application of spatial omics in disease research, rising demand for personalized nutrition, and growing expansion of clinical trials using multiomics. Major trends in the forecast period include advancement in spatial transcriptomics tools, advanced microfluidics-enabled omics workflows, development of real-time multiomics monitoring systems, innovation in cross-species multiomics applications, and development of wearable omics diagnostic technologies.
Claim your free report sample now:
Which Factors Are Driving Growth in the Multiomics Services Market?
The increasing adoption of personalized medicine is expected to propel the growth of the multiomics services market going forward. Personalized medicine refers to a medical model that uses information about a person’s genes and lifestyle environment to tailor treatments and healthcare to their specific needs. The increasing adoption of personalized medicine is due to people preferring health technologies that offer real-time monitoring and treatment plans customized to their unique biology. Multiomics services support advancing personalized medicine by integrating diverse biological data such as genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive understanding of an individual's health profile, thereby enabling tailored diagnosis, treatment, and disease prevention strategies. For instance, in February 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing adoption of personalized medicine is driving the growth of the multiomics services market.
What Are the Core Segments Shaping the Multiomics Services Market Landscape?
The multiomics services market covered in this report is segmented
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications
3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services
2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services
What Are the Notable Trends in the Multiomics Services Market by Product, Application, and Region?
Major companies operating in the multiomics services market are focusing on developing innovative approaches, such as 3D genome mapping, to enhance the understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping refers to the process of determining the three-dimensional spatial organization of the genome within the nucleus of a cell. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, launched a suite of 3D multi-omics solutions to accelerate and improve the precision of drug discovery. It offers unique features such as integration of genome-wide regulatory interaction data with multi-omics profiles in a single assay, enabling comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology allows precise mapping of long-range interactions between regulatory elements and target genes, including those in non-coding regions. The platform’s modular design featuring GenLinkConnect, GenLinkResponse, and GenLinkProfile supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, the GenLinkHub software provides an intuitive interface for 3D visualization, data management, and quality control, enhancing researchers’ ability to interpret complex datasets and accelerate drug discovery.
Which Are the Top Companies in the Multiomics Services Market?
Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., and Clinical Microbiomics A/S.
Get the full multiomics services market report here:
Which Regions Are Driving the Most Demand in the Multiomics Services Market?
North America was the largest region in the multiomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
Comments
Post a Comment